GlobeNewswire

HODL RALLY Pledges Percentage of Profits from Upcoming Crypto-Inspired Supercar Rally to Support TEWBIT Foundation

Del

HODL RALLY founder and CEO calls for support of Ghana’s most needy children

LONDON, May 13, 2019 (GLOBE NEWSWIRE) -- CryptoCurrencyWire – HODL RALLY, the world’s first cryptocurrency-inspired supercar rally, today announces it is using its leading position to raise funds and awareness for Tetnight Education & Wellbeing International (TEWBIT), a West Africa-based foundation that helps children get a quality education and learn skills to become self-sufficient farming and agriculture leaders. In support of this cause, HODL RALLY organizers have pledged 15% of the profits from their upcoming European event to the foundation.

HODL RALLY is an eight-day, eight-city European supercar rally taking place June 30-July 7, combining blockchain conferences with parties, club takeovers, poker tournaments, incredible supercars and much more. The aim of the event is to educate, inspire and raise awareness of the importance of blockchain technologies in a fun and exciting environment, fusing the natural synergy between supercars and cryptocurrencies.

HODL RALLY founder and CEO Virtue Nightingale spent time in Ghana during his youth, and he now wants to use his position of success to give back to the communities in which his heritage is rooted.  

Although Ghana has one of Africa’s fastest growing economies, nearly 30% of the population lives below the poverty level. It is rare for Ghanaians to receive a complete education. Due to overcrowded classes and a shortage of books and teachers, many children fail to complete secondary or even primary school. Some schools are even without bathroom facilities and clean running water.

“These are circumstances that we in the U.K. deem far from satisfactory,” said Nightingale. “In addition to the severe poverty experienced by many children in Ghana, children suffer violence, discrimination and abuse on a scale unacceptable in the Western world. Valuable charities such as TEWBIT, however, actively engage in tackling these problems by providing education and training to motivate and encourage these children to reach their potential, to learn and grow, to shake off illiterate and ignorant behavior, and to be stimulated to become successful in the environment in which they are raised.” 

The TEWBIT foundation takes pride in supporting and sponsoring the next generation of young farmers, enriching youth employment by providing work experience and aiding in teaching new skills, inspiring self-sufficiency through training programs, and endorsing education and guidance to promote long-term food security by way of providing grain banks.

“The results so far have led to highly productive, active engagement and enlightened men and woman capable of farming their own food and living in respectful communities where abuse against women is scorned and unacceptable,” said Nightingale. “We are proud to support TEWBIT in changing the world and encourage others to do the same.”

About HODL RALLY

HODL RALLY is the world’s first blockchain inspired supercar rally experience. The eight-day event combines blockchain conferences with parties, dinners, fashion shows, yacht parties, club takeovers and lots of supercars. Driving across Europe, the tour will hit eight cities in eight days and will wrap up with a VIP superyacht party in Ibiza. For more details, visit https://HODLRALLY.com/.

Clarity PR
Maria Jung 
Maria@Clarity.pr

CryptoCurrencyWire (CCW) Contact:
New York, New York
www.CryptoCurrencyWire.com
212.418.1217
Editor@CryptoCurrencyWire.com

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Gainsight Unveils the Customer Cloud, the Future of Customer Success Technology23.5.2019 19:30:00 CESTPressemelding

New Products Announced at Pulse 2019 to Drive Customer Success Across the Enterprise SAN FRANCISCO, May 23, 2019 (GLOBE NEWSWIRE) -- Today, Gainsight® launched the Customer Cloud —a first-of-its-kind solution for subscription businesses looking to adopt a customer-centric philosophy that enables them to retain customers while also driving company growth post-sale. According to the 2018 Subscription Economy Index report, subscription companies are growing five times faster than S&P and retail sales. The Gainsight Customer Cloud caters to these businesses by combining the company’s Customer Success and Product Experience products with three new product innovations to offer a powerful set of solutions for businesses to optimize their subscription strategies through technology. “With the maturity of cloud technology and the subscription economy, customer expectations have drastically changed. Companies are struggling to leverage existing tools to satisfy the increasing demands of their cus

Lowered Return Expectations Among Several Trends Pointing to a Shift in Private Markets Due Diligence says New eVestment Survey23.5.2019 15:30:00 CESTPressemelding

ATLANTA, May 23, 2019 (GLOBE NEWSWIRE) -- Private markets funds have continued to rake in new commitments from institutional investors eager to diversify their portfolios and capture the returns private markets investments can offer. However, investors are now tempering their private markets return expectations. Coupled with other industry trends, this will have implications for private markets fundraising and due diligence according to a new eVestment report, produced in association with parent company Nasdaq. The 2019 eVestment Private Markets Due Diligence Survey of institutional investors, consultants and private markets fund managers finds that 52% of investors expect returns in the space to decline in the future (page 16). Only 12% of investors expected private equity returns to increase, with the balance – 36% – expecting returns to stay about the same. Forty-seven percent of investors surveyed expect to see lower returns in venture capital vs. just 16% of investors who expect r

Collibra Announces 2019 Excellence Awards Winners23.5.2019 15:00:00 CESTPressemelding

American Express, Deloitte, and Lloyds Banking Group recognized as leaders in harnessing data to drive digital transformation NEW YORK, May 23, 2019 (GLOBE NEWSWIRE) -- Collibra, the leader in enterprise data governance and catalog software, today announced the winners of the 2019 Collibra Excellence Awards. Presented at the annual Data Citizens conference in New York, the awards honor teams and individuals driving innovative data strategy by collaborating with Collibra. “In today’s market, organizations that are able to maximize data have the power to transform entire industries,” said Felix Van de Maele, co-founder and CEO of Collibra. “We’re proud to honor the recipients of the Collibra Excellence Awards, a cutting-edge group at the forefront of data-driven innovation.” The 2019 Collibra Excellence Award Winners: American Express — Distinguished Data Program of the Year American Express was recognized for its data governance transformation, which began as a compliance initiative and

XBiotech Announces Plan to Launch Randomized Phase 2b Study of Bermekimab in Hidradenitis Suppurativa23.5.2019 14:20:00 CESTPressemelding

AUSTIN, Texas, May 23, 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced plans to advance its dermatology program for its true human antibody bermekimab with the launch of a randomized, double-blind, placebo controlled, Phase 2b clinical study in patients with moderate to severe Hidradenitis Suppurativa (HS). This Phase 2b study will evaluate safety and efficacy of bermekimab at different subcutaneous doses compared with placebo. The study will further evaluate efficacy of bermekimab in HS and guide dosing strategies for the anticipated Phase 3 registration study. The Company expects the first patient to be enrolled during the third quarter of 2019. The Phase 2b study follows two previous successful clinical studies of bermekimab to treat HS. XBiotech recently evaluated bermekimab in a phase 2 study involving two groups of patients with HS: those who had no prior treatment with biologics; and those who had failed the only approved biological therapy to treat HS. The study, whi

LGC CAPITAL Announces Results of Annual Meeting, Appointment of New Chairman and Approval of Name Change to Elixxer Ltd.23.5.2019 14:00:00 CESTPressemelding

MONTRÉAL, May 23, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG) (OTCQB: LGGCF) ("LGC" or the “Corporation”) is pleased to announce the results of its annual and special meeting of shareholders (the “Meeting”) held yesterday in Montreal, Quebec. At the Meeting, all five of the nominees listed in the Corporation’s management information circular dated April 17, 2019 were elected as directors, all with a vote of more than 92% of the shares voted in their favour. Accordingly, the directors of LGC for the ensuing year are Mohammed Ghafari, Mazen Haddad, Rafi Hazan, David Lenigas and Ferras Zalt. At the Meeting, shareholders adopted a special resolution approving a change in the name of the Corporation to “Elixxer Ltd.” or such other name as the Corporation’s directors may determine. The special resolution was supported by 98.94% of the votes cast at the Meeting. The Corporation intends to proceed with the name change as expeditiously as possible. Shareholders also adopted: a special

Merus Announces 2019 Annual General Meeting of Shareholders23.5.2019 14:00:00 CESTPressemelding

UTRECHT, The Netherlands, May 23, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length human bispecific antibody therapeutics, today announced that the 2019 Annual General Meeting of Shareholders will be held on June 12, 2019 at 1:00 pm (CEST) at the offices of NautaDutilh N.V. (address: Beethovenstraat 400, 1082 PR Amsterdam, the Netherlands). All relevant documents and information for the meeting, including the notice and agenda, are available in the 'Investor Relations' section of Merus’ website (www.merus.nl) under “Financial Information”. About Merus N.V. Merus is a clinical-stage immuno-oncology company developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics®. Biclonics®, which are based on the full-length IgG format, are manufactured using industry standard processes and have been observed in preclinical and clin